Article

An Immunohistochemical Panel of Three SUMO Genes Predicts Outcomes of Patients With Triple-negative Breast Cancer

2020-11-19

Abstract excerpt

<h4>Background: </h4> Triple negative breast cancer (TNBC) is a highly heterogeneous and aggressive disease. Developing new candidate biomarkers for chemotherapy response and possible therapeutic targets has become an urgent clinical need. Small ubiquitin-like modifier (SUMOs) mediate post-translational modifications (SUMOylation) that target multiple proteins was involved in many biological processes. The role of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 51487bc6-caa3-51ac-bbb1-bd6a3b16d408
DOI: 10.21203/rs.3.rs-109613/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

An Immunohistochemical Panel of Three SUMO Genes Predicts Outcomes of Patients With Triple-negative Breast CancerDOI 10.21203/rs.3.rs-109613/v1Read

The Expression and Prognostic Value of SUMO1-Activating Enzyme Subunit 1 and Its Potential Mechanism in Triple-Negative Breast CancerSemantic proximity Read

Prognostic and Therapeutic Response Analysis of Breast Cancer Based on Post-translational Ubiquitin and Ubiquitin-Like Modification-Related SignatureSemantic proximity Read

Identification of a Novel Prognostic Signature for Breast Cancer Based on Post-translational Ubiquitin and Ubiquitin-Like Modification-Related GenesSemantic proximity Read

A scoring screening system based on machine learning for immunotherapy beneficiaries in triple-negative breast cancerSemantic proximity Read

Development of a Prognostic Model Based on Identification of EMT-related LncRNAs in Triple Negative Breast CancerSemantic proximity Read

Identification of a Novel Prognostic Signature for Breast Cancer Derived from Post-translational Ubiquitin and Ubiquitin-Like Modification-Related GenesSemantic proximity Read

Breast cancer survival prediction using seven prognostic biomarker genesSemantic proximity Read

A Novel Immune-Related LncRNA Pair Model to Predict the Prognosis of Triple-Negative Breast CancerSemantic proximity Read

Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast CancerSemantic proximity Read

FOXA1 is Prognostic of Triple Negative Breast Cancers by Transcriptionally Suppressing SOD2 and IL6Semantic proximity Read

TP53 signature score predicts prognosis and immune response in triple-negative breast cancerSemantic proximity Read

Risk factors, prognostic factors, and nomograms for distant metastasis in patients with triple-negative breast cancer: a population-based studySemantic proximity Read